Final results of a phase Ib trial of PR104, a pre-prodrug of the bioreductive prodrug PR104A, in combination with gemcitabine (G) or docetaxel (D) in patients with advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 2554-2554 ◽  
Author(s):  
M. B. Jameson ◽  
M. J. McKeage ◽  
R. K. Ramanathan ◽  
J. Rajendran ◽  
Y. Gu ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Phase Ib

scholarly journals Phase IB Dose-Escalation Study of BEZ235 or BKM120 in Combination with Paclitaxel (PTX) in Patients With Advanced Solid Tumors

2012 ◽  
Vol 23 ◽  
pp. ix157-ix158
Author(s):  
L. Dirix ◽  
M. Schuler ◽  
J. Machiels ◽  
D. Hess ◽  
A. Awada ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Dose Escalation ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study ◽  
Phase Ib

Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors

2018 ◽  
Vol 19 (5) ◽  
pp. e655-e665 ◽  
Author(s):  
D. Ross Camidge ◽  
Lecia V. Sequist ◽  
Pasi A. Jänne ◽  
Andrew J. Weickhardt ◽  
Elizabeth S. Dowling ◽  
...  
Keyword(s):  
Solid Tumors ◽  
High Dose ◽  
Advanced Solid Tumors ◽  
Phase Ib

Combinations of the immunocytokine F16-IL2 with doxorubicin or with paclitaxel investigated in phase Ib studies in patients with advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e13017-e13017 ◽  
Author(s):  
F. G. De Braud ◽  
C. Catania ◽  
C. Masini ◽  
M. Maur ◽  
S. Cascinu ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Phase Ib

A phase Ib study for MNRP1685A (anti-NRP1) administered intravenously with bevacizumab with or without paclitaxel to patients with advanced solid tumors.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 3050-3050 ◽  
Author(s):  
C. D. Weekes ◽  
P. LoRusso ◽  
V. Ramakrishnan ◽  
L. M. Shih ◽  
W. C. Darbonne ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Phase Ib
Sign in / Sign up

Export Citation Format

Share Document